Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025)

Aclaris Therapeutics' (ACRS) quarterly Prepaid Assets came in at $4.2 million in Q2 2025, down 32.41% year-on-year from $6.2 million in Q2 2024, and up 30.25% quarter-over-quarter from $3.2 million in Q1 2025.

Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025) Analysis & Trends

Aclaris Therapeutics' Prepaid Assets history runs 12 years deep, the most recent figure standing at $4.2 million for Q2 2025.

  • On a quarterly basis, Prepaid Assets fell 32.41% year-over-year to $4.2 million in Q2 2025; TTM through Jun 2025 was $4.2 million, a 32.41% decrease from a year earlier, with the FY2024 full-year figure at $12.0 million, up 27.37% from the prior year.
  • Prepaid Assets improved to $4.2 million in Q2 2025 per ACRS's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $19.7 million in Q3 2023 and bottomed at $3.2 million in Q1 2025.
  • The 5-year median for Prepaid Assets is $9.0 million (2021), against an average of $9.3 million.
  • Across the five-year window, Prepaid Assets jumped 401.74% in 2021 and sank 78.32% in 2024, its largest moves.
  • Year by year, Prepaid Assets stood at $13.0 million in 2021, then increased by 3.85% to $13.5 million in 2022, then dropped by 29.96% to $9.5 million in 2023, then gained by 27.37% to $12.0 million in 2024, then tumbled by 65.1% to $4.2 million in 2025.
  • Per Business Quant, the three latest ACRS Prepaid Assets figures stand at $4.2 million (Q2 2025), $3.2 million (Q1 2025), and $12.0 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Aclaris Therapeutics 705.88 Mn 705.88 Mn 1.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 4.20 Mn
Mar 31, 2025 3.23 Mn
Dec 31, 2024 12.04 Mn
Sep 30, 2024 4.27 Mn
Jun 30, 2024 6.22 Mn
Mar 31, 2024 6.80 Mn
Dec 31, 2023 9.45 Mn
Sep 30, 2023 19.67 Mn
Jun 30, 2023 12.73 Mn
Mar 31, 2023 12.87 Mn
Dec 31, 2022 13.50 Mn
Sep 30, 2022 7.91 Mn
Jun 30, 2022 10.11 Mn
Mar 31, 2022 10.63 Mn
Dec 31, 2021 13.00 Mn
Sep 30, 2021 7.09 Mn
Jun 30, 2021 8.65 Mn
Mar 31, 2021 5.39 Mn
Dec 31, 2020 2.59 Mn
Sep 30, 2020 1.88 Mn